CN100417665C - 松花粉多糖的制备方法、松花粉多糖及其在药物中的应用 - Google Patents
松花粉多糖的制备方法、松花粉多糖及其在药物中的应用 Download PDFInfo
- Publication number
- CN100417665C CN100417665C CNB2006100758397A CN200610075839A CN100417665C CN 100417665 C CN100417665 C CN 100417665C CN B2006100758397 A CNB2006100758397 A CN B2006100758397A CN 200610075839 A CN200610075839 A CN 200610075839A CN 100417665 C CN100417665 C CN 100417665C
- Authority
- CN
- China
- Prior art keywords
- pine pollen
- polysaccharide
- pollen
- pine
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 41
- 238000000034 method Methods 0.000 title claims abstract description 18
- 150000004676 glycans Chemical class 0.000 claims abstract description 76
- 229920001282 polysaccharide Polymers 0.000 claims abstract description 76
- 239000005017 polysaccharide Substances 0.000 claims abstract description 76
- 235000008331 Pinus X rigitaeda Nutrition 0.000 claims abstract description 71
- 235000011613 Pinus brutia Nutrition 0.000 claims abstract description 71
- 241000018646 Pinus brutia Species 0.000 claims abstract description 71
- 238000002360 preparation method Methods 0.000 claims abstract description 22
- 210000004369 blood Anatomy 0.000 claims abstract description 20
- 239000008280 blood Substances 0.000 claims abstract description 20
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 14
- 238000001035 drying Methods 0.000 claims abstract description 10
- 238000000108 ultra-filtration Methods 0.000 claims abstract description 10
- 230000008569 process Effects 0.000 claims abstract description 8
- 229920002678 cellulose Polymers 0.000 claims abstract description 6
- 239000001913 cellulose Substances 0.000 claims abstract description 6
- 238000000605 extraction Methods 0.000 claims abstract description 6
- 108010019160 Pancreatin Proteins 0.000 claims abstract description 4
- 238000010828 elution Methods 0.000 claims abstract description 4
- 238000000703 high-speed centrifugation Methods 0.000 claims abstract description 4
- 229940055695 pancreatin Drugs 0.000 claims abstract description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 21
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 10
- 239000008103 glucose Substances 0.000 claims description 10
- 238000001556 precipitation Methods 0.000 claims description 10
- 239000000284 extract Substances 0.000 claims description 9
- 206010020772 Hypertension Diseases 0.000 claims description 8
- 238000010438 heat treatment Methods 0.000 claims description 7
- 238000003756 stirring Methods 0.000 claims description 6
- 230000002929 anti-fatigue Effects 0.000 claims description 5
- 238000001728 nano-filtration Methods 0.000 claims description 5
- 238000001291 vacuum drying Methods 0.000 claims description 5
- 238000010792 warming Methods 0.000 claims description 5
- 235000011609 Pinus massoniana Nutrition 0.000 claims description 4
- 241000018650 Pinus massoniana Species 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 4
- 230000003053 immunization Effects 0.000 claims description 4
- 239000012535 impurity Substances 0.000 claims description 4
- 238000009413 insulation Methods 0.000 claims description 4
- 108010059892 Cellulase Proteins 0.000 claims description 3
- 229940106157 cellulase Drugs 0.000 claims description 3
- 239000012528 membrane Substances 0.000 claims description 3
- 230000001105 regulatory effect Effects 0.000 claims description 3
- 239000006228 supernatant Substances 0.000 claims description 3
- 238000005406 washing Methods 0.000 claims description 3
- 239000003513 alkali Substances 0.000 claims description 2
- 238000009835 boiling Methods 0.000 claims description 2
- 239000000706 filtrate Substances 0.000 claims description 2
- 238000002386 leaching Methods 0.000 claims description 2
- 230000036772 blood pressure Effects 0.000 abstract description 12
- 230000000694 effects Effects 0.000 abstract description 9
- 230000036039 immunity Effects 0.000 abstract description 2
- 239000003480 eluent Substances 0.000 abstract 2
- 238000012869 ethanol precipitation Methods 0.000 abstract 2
- 239000010813 municipal solid waste Substances 0.000 abstract 2
- GUBGYTABKSRVRQ-UHFFFAOYSA-N 2-(hydroxymethyl)-6-[4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxane-3,4,5-triol Chemical compound OCC1OC(OC2C(O)C(O)C(O)OC2CO)C(O)C(O)C1O GUBGYTABKSRVRQ-UHFFFAOYSA-N 0.000 abstract 1
- BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 abstract 1
- 238000005336 cracking Methods 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 238000010298 pulverizing process Methods 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 238000002474 experimental method Methods 0.000 description 34
- 241000699666 Mus <mouse, genus> Species 0.000 description 19
- 241000700159 Rattus Species 0.000 description 18
- 239000000243 solution Substances 0.000 description 15
- 241001465754 Metazoa Species 0.000 description 8
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 8
- 230000037396 body weight Effects 0.000 description 7
- 238000003304 gavage Methods 0.000 description 7
- 239000002504 physiological saline solution Substances 0.000 description 6
- 210000002966 serum Anatomy 0.000 description 6
- 108010023302 HDL Cholesterol Proteins 0.000 description 5
- 108010028554 LDL Cholesterol Proteins 0.000 description 5
- 230000000242 pagocytic effect Effects 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 230000009182 swimming Effects 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 238000013299 hypertensive rat model Methods 0.000 description 4
- 150000002632 lipids Chemical class 0.000 description 4
- 210000000865 mononuclear phagocyte system Anatomy 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 208000031226 Hyperlipidaemia Diseases 0.000 description 3
- 238000010171 animal model Methods 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000010172 mouse model Methods 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 230000035488 systolic blood pressure Effects 0.000 description 3
- 210000001541 thymus gland Anatomy 0.000 description 3
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 3
- 206010002091 Anaesthesia Diseases 0.000 description 2
- 238000011725 BALB/c mouse Methods 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 238000012449 Kunming mouse Methods 0.000 description 2
- 230000037005 anaesthesia Effects 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 238000009530 blood pressure measurement Methods 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 201000005577 familial hyperlipidemia Diseases 0.000 description 2
- 201000001421 hyperglycemia Diseases 0.000 description 2
- 230000002218 hypoglycaemic effect Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000011552 rat model Methods 0.000 description 2
- QGMRQYFBGABWDR-UHFFFAOYSA-N sodium;5-ethyl-5-pentan-2-yl-1,3-diazinane-2,4,6-trione Chemical compound [Na+].CCCC(C)C1(CC)C(=O)NC(=O)NC1=O QGMRQYFBGABWDR-UHFFFAOYSA-N 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010008132 Cerebral thrombosis Diseases 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 108010015776 Glucose oxidase Proteins 0.000 description 1
- 239000004366 Glucose oxidase Substances 0.000 description 1
- 241000282414 Homo sapiens Species 0.000 description 1
- 208000013016 Hypoglycemia Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- YQEZLKZALYSWHR-UHFFFAOYSA-N Ketamine Chemical compound C=1C=CC=C(Cl)C=1C1(NC)CCCCC1=O YQEZLKZALYSWHR-UHFFFAOYSA-N 0.000 description 1
- HWGBHCRJGXAGEU-UHFFFAOYSA-N Methylthiouracil Chemical compound CC1=CC(=O)NC(=S)N1 HWGBHCRJGXAGEU-UHFFFAOYSA-N 0.000 description 1
- 241000700157 Rattus norvegicus Species 0.000 description 1
- 201000003099 Renovascular Hypertension Diseases 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 238000000540 analysis of variance Methods 0.000 description 1
- 210000000709 aorta Anatomy 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000002612 cardiopulmonary effect Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229940099352 cholate Drugs 0.000 description 1
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000011697 diabetes animal model Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 229940097896 diazepam 5 mg Drugs 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000003811 finger Anatomy 0.000 description 1
- 235000021191 food habits Nutrition 0.000 description 1
- 150000002303 glucose derivatives Chemical class 0.000 description 1
- 229940116332 glucose oxidase Drugs 0.000 description 1
- 235000019420 glucose oxidase Nutrition 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000001631 hypertensive effect Effects 0.000 description 1
- 208000021822 hypotensive Diseases 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229960003299 ketamine Drugs 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- OQUKIQWCVTZJAF-UHFFFAOYSA-N phenol;sulfuric acid Chemical compound OS(O)(=O)=O.OC1=CC=CC=C1 OQUKIQWCVTZJAF-UHFFFAOYSA-N 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 108700022737 rat Fat1 Proteins 0.000 description 1
- 230000003716 rejuvenation Effects 0.000 description 1
- 210000002254 renal artery Anatomy 0.000 description 1
- 210000002796 renal vein Anatomy 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000000405 serological effect Effects 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 210000003813 thumb Anatomy 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 210000002417 xiphoid bone Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
组别 | TC(mmol/L) | TG(mmol/L) | LDL-C(mmol/L) | HDL-L(mmol/L) |
空白对照组 | 4.35±0.86 | 0.61±0.13 | 2.83±0.34 | 0.96±0.18 |
模型对照组 | 13.85±2.06<sup>#</sup> | 1.63±0.34<sup>#</sup> | 9.72±1.18<sup>#</sup> | 0.42±0.13<sup>#</sup> |
实验药物I组 | 6.89±1.60<sup>*</sup> | 0.61±0.18<sup>*</sup> | 3.31±0.50<sup>*</sup> | 0.98±0.35<sup>*</sup> |
实验药物II组 | 6.52±1.72<sup>*</sup> | 0.57±0.12<sup>*</sup> | 3.31±0.50<sup>*</sup> | 1.22±0.20<sup>*</sup> |
组别 | 游泳时间(min) |
空白对照组 | 20.35±11.27 |
实验药物I组 | 30.86±10.36<sup>#</sup> |
实验药物II组 | 41.21±14.11<sup>*</sup> |
组别 | 胸腺指数(mg/10g) | 脾脏指数(mg/10g) |
空白对照组 | 26.54±6.34 | 39.20±10.83 |
实验药物I组 | 32.91±5.77# | 46.37±7.70# |
实验药物II组 | 40.64±7.62* | 53.64±9.78* |
组别 | 吞噬指数 |
空白对照组 | 0.0039±0.0020 |
实验药物I组 | 0.0068±0.0024<sup>#</sup> |
实验药物II组 | 0.0084±0.0021<sup>*</sup> |
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006100758397A CN100417665C (zh) | 2006-04-20 | 2006-04-20 | 松花粉多糖的制备方法、松花粉多糖及其在药物中的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006100758397A CN100417665C (zh) | 2006-04-20 | 2006-04-20 | 松花粉多糖的制备方法、松花粉多糖及其在药物中的应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1858068A CN1858068A (zh) | 2006-11-08 |
CN100417665C true CN100417665C (zh) | 2008-09-10 |
Family
ID=37297028
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2006100758397A Expired - Fee Related CN100417665C (zh) | 2006-04-20 | 2006-04-20 | 松花粉多糖的制备方法、松花粉多糖及其在药物中的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100417665C (zh) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101117354B (zh) * | 2007-09-04 | 2011-01-19 | 山东师范大学 | 一种酯化松花粉多糖及制备方法和用途 |
CN101411727B (zh) * | 2008-12-01 | 2011-09-28 | 浙江亚林生物科技股份有限公司 | 一种松花粉精片的配方及其制备工艺 |
CN101518552B (zh) * | 2009-04-10 | 2012-01-04 | 南京师范大学 | 松花粉与环糊精组合物、其制备方法及其在制备抗疲劳与提高机体免疫力保健品中的应用 |
CN102372787B (zh) * | 2010-08-10 | 2014-06-11 | 卢卫红 | 一种具有抗辐射作用的玉米花粉多糖的膜分离制取方法 |
CN103130902B (zh) * | 2011-11-29 | 2015-04-22 | 烟台新时代健康产业有限公司 | 一种从松花粉中提取粗多糖的方法 |
CN102746413B (zh) * | 2012-07-16 | 2014-04-02 | 桐庐兴源保健品有限公司 | 蜂花粉多糖酶解破壁结合热水超声浸提方法 |
CN103948018B (zh) * | 2014-04-24 | 2016-01-20 | 邱银平 | 双茸猴头松花食品及其制备方法 |
CN106135705A (zh) * | 2016-08-18 | 2016-11-23 | 广州暨南生物医药研究开发基地有限公司 | 一种保健型猪饲料添加剂及其制备和使用方法 |
CN108902286A (zh) * | 2018-07-23 | 2018-11-30 | 郑州成济堂生物科技有限公司 | 一种虹鳟鱼复合保鲜剂的制备方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1569903A (zh) * | 2004-04-28 | 2005-01-26 | 中国食品发酵工业研究院 | 酶解制备灵芝多糖的方法 |
-
2006
- 2006-04-20 CN CNB2006100758397A patent/CN100417665C/zh not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1569903A (zh) * | 2004-04-28 | 2005-01-26 | 中国食品发酵工业研究院 | 酶解制备灵芝多糖的方法 |
Non-Patent Citations (6)
Title |
---|
珍贵的金色粉末松花粉. 刘建文.中国保健营养,第6期. 2004 |
珍贵的金色粉末松花粉. 刘建文.中国保健营养,第6期. 2004 * |
蒲黄花粉多糖提取工艺研究. 李道荣,李魁,段雪梅.郑州工程学院学报,第23卷第4期. 2002 |
蒲黄花粉多糖提取工艺研究. 李道荣,李魁,段雪梅.郑州工程学院学报,第23卷第4期. 2002 * |
蜜蜂花粉多糖研究进展. 曾志将,邹阳,杨明.养蜂科技,第2期. 2005 |
蜜蜂花粉多糖研究进展. 曾志将,邹阳,杨明.养蜂科技,第2期. 2005 * |
Also Published As
Publication number | Publication date |
---|---|
CN1858068A (zh) | 2006-11-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100417665C (zh) | 松花粉多糖的制备方法、松花粉多糖及其在药物中的应用 | |
CN102349975B (zh) | 一种铁皮石斛保健品配方、组合物以及组合物的制备方法和用途 | |
CN102846852A (zh) | 一种降血脂、调节免疫力的组合物 | |
CN105543052A (zh) | 一种养生补肾黄秋葵酒及其制备方法 | |
CN107412721A (zh) | 一种降血糖苦瓜多肽复方胶囊及其制备方法 | |
CN102336931A (zh) | 麦冬多糖及其制备方法和应用 | |
CN101664180B (zh) | 一种具有保健功效的营养复合剂及其制备方法 | |
CN107581620A (zh) | 一种降血糖苦瓜多肽复合含片及其制备方法 | |
CN105362285A (zh) | 一种具有促进胃排空作用的复合多糖的制备方法及复合多糖的应用 | |
CN102233056A (zh) | 一种治疗糖尿病及其综合症的中草药组合物 | |
CN1434053A (zh) | 知母提取物及其制备方法和用途 | |
CN101348812A (zh) | 一种地衣多糖及其制备方法和应用 | |
CN102512438B (zh) | 太子参多糖在制备预防、治疗糖尿病药物和保健食品中的应用 | |
CN1558768A (zh) | 一种中药组合物及其制备方法 | |
CN105017442B (zh) | 人参多糖的提取方法 | |
CN105111323B (zh) | 一种具有抗肿瘤活性的龙葵精制多糖的提取纯化方法 | |
CN107912771A (zh) | 一种具有增强免疫功能的石斛组合物及其制备方法 | |
CN102114202B (zh) | 一种保肝组合物及其制备方法 | |
CN100509856C (zh) | 一种隐孔菌多糖及其制备与应用 | |
CN1884571B (zh) | 从石蒜属植物中提取多糖的工艺方法 | |
CN105012826A (zh) | 一种益智叶提取物及其制备方法、应用 | |
CN103479875A (zh) | 一种高活性玉竹浓缩液的制备方法及其应用 | |
CN108260682A (zh) | 一种降血糖、降血脂和降血压的保健茶 | |
CN106879774A (zh) | 一种具有辅助降血糖作用的复方茶及其制备方法 | |
CN105768095A (zh) | 一种提高免疫力的保健食品组合物及其制剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Assignee: HAINAN JINXING PHARMACEUTICAL CO., LTD. Assignor: Xia Zhongning Contract record no.: 2010990000538 Denomination of invention: Method for preparing pollen pini polyose, pollen pipe polyose and its use in medicine Granted publication date: 20080910 License type: Exclusive License Open date: 20061108 Record date: 20100723 |
|
ASS | Succession or assignment of patent right |
Owner name: LIU QUANSHENG Free format text: FORMER OWNER: XIA ZHONGNING Effective date: 20120307 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 570125 HAIKOU, HAINAN PROVINCE TO: 570216 HAIKOU, HAINAN PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20120307 Address after: 570216 Comprehensive Bonded Zone 168, Nanhai Avenue, Longhua District, Hainan, Haikou, A06-2 Patentee after: Liu Quansheng Address before: The new business building, No. 48 Hainan 570125 Haikou Jinmao China World Trade Center District Road 27 layer 2703 Patentee before: Xia Zhongning |
|
ASS | Succession or assignment of patent right |
Owner name: HAINAN QUANXING PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: LIU QUANSHENG Effective date: 20141104 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20141104 Address after: 570216 Haikou Free Trade Zone, Hainan, A06-2 Patentee after: HAINAN JINXING PHARMACEUTICAL CO., LTD. Address before: 570216 Comprehensive Bonded Zone 168, Nanhai Avenue, Longhua District, Hainan, Haikou, A06-2 Patentee before: Liu Quansheng |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20080910 Termination date: 20150420 |
|
EXPY | Termination of patent right or utility model |